Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
ID06700915

A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and Metabolism

Led by Ultimate International, Inc. · Updated on 2024-12-13

80

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

Ultimate International, Inc.

Lead Sponsor

C

Citruslabs

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of Diaberine, a berberine-based nutraceutical, on blood sugar regulation and metabolism in adults with metabolism disorder. This randomized, triple-blind, placebo-controlled trial will study 80 participants aged 18 to 70 over 24 weeks to assess how well this dietary supplement may aid in these health areas. Participants will be randomly assigned to one of two groups. One group will take Diaberine capsules containing Vitamin B12, berberine, magnesium citrate, cinnamon bark extract, chromium, and other ingredients three times daily, 15 minutes before meals. The other group will take placebo capsules with similar appearance but without the active ingredients. Both treatments will continue for 24 weeks with regular monitoring. During the study, participants will have their blood sugar regulation and metabolism measured at baseline, week 12, and week 24. Additionally, quality of life and weight changes will be tracked at multiple points throughout the 24 weeks. Participants will be monitored through questionnaires, blood tests, and weight assessments to evaluate the supplement's effects and tolerance over time.

CONDITIONS

Brief Title

A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and Metabolism

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female.
  • Body mass index (BMI) between 27 and 35 kg/m2.
  • HbA1c levels between 5.7% and 6.4% as determined by prescreening blood test.
  • Be generally healthy.
  • Willing to avoid taking any products, prescription medications, or supplements that target blood sugar regulation or metabolism during the study.
  • Willing to maintain current diet, sleep schedule, and activity level during the study.
Not Eligible

You will not qualify if you...

  • Diagnosed with Type 2 diabetes and prescribed medications such as metformin, insulin, or similar drugs.
  • Use or history within 8 weeks of certain prescription medications including beta-blockers, thiazide diuretics, corticosteroids, or immunosuppressants.
  • Women who are pregnant, breastfeeding, or trying to conceive.
  • Unwilling or unable to follow the study protocol.
  • Pre-existing chronic conditions including cancer or psychiatric disorders that prevent adherence.
  • Planning significant medical procedures within 6 months.
  • Major illness in the last 3 months.
  • History of severe allergic reactions to product ingredients.
  • Heavy alcohol or drug use.
  • Impaired liver function.
  • Taking medications or herbal remedies affecting blood sugar or metabolism.
  • Currently treated for infection with antibiotics or antiviral medications.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 24 weeks

Participants take one capsule three times daily, 15 minutes prior to meals, for 24 weeks to assess the efficacy and tolerance of the berberine-based nutraceutical formula.

Visits at Baseline, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 24

Trial Site Locations

Total: 1 location

1

Citruslabs

Santa Monica, California, United States, 90404

Actively Recruiting

Loading map...

Research Team

P

Patrick Renner, MSc

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Umbilical Cord Blood Transplantation From Unrelated Donors t...

Acute Leukemia

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here